BOOM
Citations are updated once a week. Recently added citations may not appear.
| Context | Citation |
|---|---|
| fucoidan {Brown Algae Extract} - Akkermansia muciniphila ATCC BAA-835 |
👶
Fucoidan from Undaria pinnatifida Enhances Exercise Performance and Increases the Abundance of Beneficial Gut Bacteria in Mice. Marine drugs (Mar Drugs ) Vol: 22 Issue 11 Pages: Pub: 2024 Oct 29 Epub: 2024 Oct 29 Authors Yang C , Dwan C , Wimmer BC , Wilson R , Johnson L , Caruso V , Html Article Publication |
| fucoidan {Brown Algae Extract} - Akkermansia muciniphila ATCC BAA-835 |
👶
Low molecular weight fucoidan fraction LF2 improves metabolic syndrome via up-regulating PI3K-AKT-mTOR axis and increasing the abundance of Akkermansia muciniphila in the gut microbiota. International journal of biological macromolecules (Int J Biol Macromol ) Vol: 193 Issue Pt A Pages: 789-798 Pub: 2021 Dec 15 Epub: 2021 Oct 30 Authors Deng Z , Wu N , Wang J , Geng L , Yue Y , Wang F , Zhang Q , Publication |
| fucoidan {Brown Algae Extract} - Akkermansia muciniphila ATCC BAA-835 |
👶
Fucoidan ameliorates rotenone-induced Parkinsonism in mice by regulating the microbiota-gut-brain axis. International journal of biological macromolecules (Int J Biol Macromol ) Vol: 283 Issue Pt 2 Pages: 137373 Pub: 2024 Nov 7 Epub: 2024 Nov 7 Authors Yang X , Zhang X , Ma Y , Li S , Wang Q , Hong JS , Yu G , Qi B , Wang J , Liu C , Shang Q , Wu X , Zhao J , Publication |
BOOM
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
